Overall, the cGAS‐STING pathway activation‐induced DNA repair may be the underlying mechanism of relapse and progression after chemotherapy in patients with PTCL. This evidence concerns the gene STING1 and mature T-cell and NK-cell non-Hodgkin lymphoma.